cancer, endometrial cancer, and ovarian cancer are the three most common types of
gynecological malignancies, ranking in the top ten for female cancer incidence [1].
The occurrence of gynecological tumors is influenced by various factors, including
genetic factors, hormonal imbalance, obesity, persistent HPV infection, and chronic
diseases such as endometriosis.
The human microbiota is a community of microorganisms residing in specific
environments of the human organism [2]. It plays a crucial role in maintaining
organismal balance and host health. It possesses many important functions, including
nutrient absorption, maintenance of epithelial barrier integrity, clearance of harmful
substances, regulation of inflammation and immune responses, and defense against
pathogen invasion [3]. In recent years, with the development of next-generation
sequencing technologies, we have gained a deeper understanding of the diversity of
the human microbiota. Among them, the gut microbiota has been extensively studied,
and the normal gut microbiota is mainly composed of the phyla Bacteroidetes and
Firmicutes [4]. The dominant microbiota in the gut of healthy individuals ferment
carbohydrates, proteins, and peptides to produce short-chain fatty acids (SCFAs).
These SCFAs help maintain an acidic environment in the gut, promote the growth of
beneficial bacteria, and inhibit the colonization of potential pathogens. Additionally,
SCFAs contribute to maintaining gut barrier function by stimulating intestinal
epithelial cell regeneration and promoting the production of antimicrobial peptides
and mucus. In conclusion, a healthy gut microbiota plays a significant role in
suppressing chronic inflammation, obesity, metabolic syndrome, and diseases related
to cancer [5].
Microbial communities in each body site exist within a host in a symbiotic
equilibrium.However, several factors can influence the composition of the microbial
community, such as medication, obesity, diet, exercise, race, geography, and genetics
[5]. Intestinal dysbiosis refers to a decrease in the diversity and stability of the
intestinal microbiota, leading to the overgrowth of opportunistic pathogens and the
production of specific bacterial byproducts, resulting in immunological and metabolic
disturbances. Research has reported associations between intestinal dysbiosis and
diseases such as inflammatory bowel disease, diabetes, obesity, metabolic syndrome,
and cancer [5]. In recent years, the relationship between gut microbiota and tumors
has become a hot topic. Previous studies have mainly confirmed the promoting effect
of microbial dysbiosis on gastrointestinal tumors, such as colorectal cancer and liver
cancer. In addition to the digestive tract, there is also a connection between gut
microbiota and the occurrence of cancers in other sites like the skin, oral cavity, lung,
and reproductive tract [7]. The mechanisms by which microorganisms drive
carcinogenesis involve multiple aspects. For gynecological cancers, in addition to
regulating inflammatory responses, intestinal dysbiosis plays a crucial role in the
occurrence of gynecological tumors through DNA damage, influencing estrogen
levels, and producing toxins and metabolites associated with intestinal bacteria [8].